Catabasis pharmaceuticals inc (CATB)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Sep'14Jun'14
Revenue

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

19,409

18,317

17,713

16,913

15,992

17,042

17,372

18,251

18,531

18,682

20,953

22,113

24,412

25,450

25,860

25,737

24,850

23,030

20,903

18,812

0

0

0

General and administrative

9,387

8,771

8,716

8,842

9,074

9,329

8,623

8,938

8,941

8,912

9,602

9,523

9,701

10,108

10,359

10,400

9,655

8,629

7,392

6,646

0

0

0

Total operating expenses

28,796

27,088

26,429

25,755

25,066

26,371

25,995

27,189

27,472

27,594

30,555

31,636

34,113

35,558

36,219

36,137

34,505

31,659

28,295

25,458

0

0

0

Loss from operations

-28,796

-27,088

-26,429

-25,755

-25,066

-26,371

-25,745

-26,689

-26,972

-27,094

-30,305

-31,636

-34,113

-35,558

-36,219

-36,137

-34,505

-31,659

-28,295

-25,458

0

0

0

Other income (expense):
Interest expense

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

276

370

462

556

650

743

837

930

1,013

1,072

978

767

0

0

0

-

Interest and investment income

786

845

870

833

619

425

284

152

153

160

187

192

228

242

0

0

0

-

-

-

-

-

-

Other (expense) income, net

-197

-50

-184

24

234

176

335

168

49

32

29

47

110

93

78

63

-24

7

13

16

0

0

0

Total other income, net

589

795

686

847

810

501

438

44

-168

-270

-340

-411

-405

-502

-669

-817

-1,043

-971

-754

-469

0

0

0

Net loss

-28,207

-26,293

-25,743

-24,908

-24,256

-25,870

-25,307

-26,645

-27,140

-27,364

-30,645

-32,047

-34,518

-36,060

-36,888

-36,954

-35,548

-32,630

-29,049

-25,927

0

0

0

Net loss per share - basic and diluted (in dollars per share)

-0.50

-0.55

-0.56

-0.62

-0.62

0.54

-0.80

-1.98

-2.88

-11.58

-0.31

-0.32

-0.41

-0.46

-0.54

-0.61

-0.61

17.70

-0.55

-8.07

-13.14

-13.55

-13.42

Weighted-average common shares outstanding used in net loss per share - basic and diluted (in shares)

15,898

11,980

11,624

11,505

9,686

7,186

7,103

3,272

2,655

-54,780

22,563

21,796

19,093

18,698

15,512

15,373

15,335

15,378

15,297

996

494

444

399